Angle: Todd Druley

Angle has appointed Todd Druley as its chief medical officer. Druley previously served as chief medical officer at ArcherDx, where he oversaw the establishment of new translational applications for that company's assays, including its patient-specific Personalized Cancer Monitoring assay. Druley taught for 15 years at Washington University, where he published over 60 peer-reviewed and invited manuscripts. His clinical focus is leukemia, and Druley has patented and licensed various technologies for error-corrected next-generation sequencing for quantitative clonal hematopoiesis and molecular residual disease detection.